LC/MS identification of 12 intracellular cytoskeletal and inflammatory proteins from monocytes adherent on surface-adsorbed fibronectin-derived peptides

Journal of Biomedical Materials Research - Part A

Volumn 85, Issue 2, 2008, Pages 513-529

  Zuckerman, Sean T ^a   Kao, Weiyuan John ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

AG18; Host response; Inflammation; Phorbol myristate acetate; PHSRN; RGD; U937

Indexed keywords

INFLAMMATION; PHORBOL MYRISTATE ACETATE; PHOSPHOTYROSINE PROTEINS; PROMONOCYTIC CELLS;

CELLS; IMMUNOLOGY; MASS SPECTROMETRY; POLYSTYRENES; PRECIPITATION (CHEMICAL); TISSUE CULTURE;

PEPTIDES;

ALPHA TUBULIN; BETA ACTIN; CARRIER PROTEINS AND BINDING PROTEINS; CASPASE RECRUITMENT DOMAIN PROTEIN 5; ELONGATION FACTOR 1ALPHA; FIBRONECTIN; GLYCOPROTEIN; GLYCOPROTEIN 96; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 90BETA; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN D0; HIGH MOBILITY GROUP B1 PROTEIN; MOESIN; PEPTIDE DERIVATIVE; PLASMINOGEN ACTIVATOR INHIBITOR 2; POLYSTYRENE; RIBONUCLEAR PROTEIN A2; RIBONUCLEOPROTEIN; UNCLASSIFIED DRUG; VIMENTIN;

ARTICLE; CELL ADHESION; CELL STRAIN U937; CONTROLLED STUDY; CYTOSKELETON; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNE RESPONSE; IMMUNOPRECIPITATION; INFLAMMATION; MONOCYTE; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; TANDEM MASS SPECTROMETRY;

CELL ADHESION; CHROMATOGRAPHY, LIQUID; CYTOKINES; FIBRONECTINS; HUMANS; INFLAMMATION MEDIATORS; MASS SPECTROMETRY; MONOCYTES; PEPTIDES; PHOSPHORYLATION; U937 CELLS;

EID: 42149093968     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.31306     Document Type: Article

References (77)

1. Anderson JM. Biological responses to materials. Annu Rev Mater Res 2001;31:81-110.
2. Hamilton JA. Nondisposable materials, chronic inflammation, and adjuvant action. J Leuk Bio 2003;73:702-712.
3. Anderson, JM. Mechanisms of inflammation and infection with implanted devices. Cardiovasc Pathol 1993;2:33S-41S.
4. Anderson JM. Inflammatory response to implants. ASAIO. 1988;11:101-107.
5. Juliano RL. Signal transduction by cell adhesion receptors and the cytoskeleton: Functions of integrins, Cadherins, selectins, and immunoglobulin-superfamily members. Annu Rev Phamacol Toxicol 2002;42:283-323.
6. Mograbi B, Rochet N, Emiliozzi C, Bernard R. Adhesion of human monocytic THP-1 cells to endothelial cell adhesion molecules or extracellular matrix proteins via β1 integrins regulates heparin binding epidermal growth factor-like growth factor (HB-EGF) expression. Euro Cytokine Network 1999;10:79-86.
7. MacEwan MR, Brodbeck WG, Matsuda T, Anderson JM. Monocyte/lymphocyte interactions and the foreign body response: In vitro effects of biomaterial surface chemistry. J Biomed Mater Res Part A 2005;74:285-293.
8. Collier TO, Anderson JM. Protein and surface effects on monocyte and macrophage adhesion, maturation, and survival. J Biomed Mater Res 2002;60:487-496.
9. Maxeiner H, Husemann J, Thomas CA, Loike JD, El Khoury J, Silverstein SC. Complementary roles for scavenger receptor A and CD36 of human monocyte-derived macro-phages in adhesion to surfaces coated with oxidized low-density lipoproteins and in secretion of H2O2. J Exp Med 1998;188:2257-2265.
10. Schmidt DR, Kao WJ. The interrelated role of fibronectin and interleukin-1 in biomaterial-modulated macrophage function. Biomaterials 2007;28:371-382.
11. Ruoslahti E. RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol 1996;12:697-715.
12. Ochsenhirt SE, Kokkoli E, McCarthy JB, Tirrell M. Effect of RGD secondary structure and the synergy site PHSRN on cell adhesion, spreading and specific integrin engagement. Biomaterials 2006;27:3863-3874.
13. Larsen CC, Kligman F, Kottke-Marchant K, Marchant RE. The effect of RGD fluorosurfactant polymer modification of ePTFE on endothelial cell adhesion, growth and function. Biomaterials 2006;27:4846-4855.
14. Fischer E. Cell signaling by protein tyrosine phosphorylation. Adv Enzyme Regul 1999;39:359-369.
15. Hunter T. Tyrosine phosphorylation in signaling and disease. Keio J Med 2002;51:61-71.
16. Mann M, Ong SE, Gronborg M, Steen H, Jensen ON, Pandey A. Analysis of protein phosphorylation using mass spectrometry: Deciphering the phosphoproteome. Trends Biotech 2002; 20:261-268.
17. Chen XX, Zuckerman ST, Kao WJ. Intracellular protein phosphorylation in adherent U937 monocytes mediated by various culture conditions and fibronectin-derived surface ligands. Biomaterials 2005;26:873-882.
18. Langrea MA, Wallis BS, Gillespie JW, Gannot G, Emmert-Buck MR, Chuaqui RF. Novel proteomic approaches for tissue analysis. Expert Rev Proteomics 2004;1:185-192.
19. Barker S, Weinfeld M, Zheng J, Li L, Murray D. Identification of mammalian proteins cross-linked to DNA by ionizing radiation. J Biol Chem 2005;280:33826-33838.
20. Verhoeckx KCM, Bijlsma S, de Groene EM, Witkamp RF, van der Greef J, Rodenburg RJT. A combination of proteomics, principal component analysis and transcriptomics is a powerful tool for the identification of biomarkers for macrophage maturation in the U937 cell line. Proteomics 2004;4:1014-1028.
21. Aebersold R, Mann M. Mass spectrometry-based proteomics. Nature 2003;422:198-207.
22. Steen H, Mann M. The ABC's (and XYZ's) of peptide sequencing. Nat Rev 2004;5:699-711.
23. Rappsilber J, Mann M. What does it mean to identify a protein in proteomics? Trends Biochem Sci 2002;27:74-78.
24. Sundstrom C, Nilsson K. Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int J Cancer 1976;17:565-577.
25. Pappin DJC, Hojrup P, Bleasby AJ. Rapid identification of proteins by peptide-mass fingerprinting. Curr Biol 1993;3:327-332.
26. Machida K, Mayer BJ, Nollau P. Profiling the global tyrosine phosphorylation state. Mol Cell Proteomics 2003;2:215-233.
27. Biswas C, Sriram U, Ciric B, Ostrovsky O, Gallucci S, Argon Y. The N-terminal fragment of GRP94 is sufficient for peptide presentation via professional antigen-presenting cells. Int Immunol 2006;18:1147-1157.
28. Warger T, Hilf N, Rechtsteiner G, Haselmayer P, Carrick DM, Jonuleit H, von Landenberg P, Rammensee HG, Nicchitta CV, Radsak MP, Schild H. Interaction of TLR2 and TLR4 ligands with the N-terminal domain of Gp96 amplifies innate and adaptive immune responses. J Biol Chem 2006;281:22545-22553.
29. Ramirez SR, Singh-Jasuja H, Warger T, Braedel-Ruoff S, Hilf N, Wiemann K, Rammensee HG, Schild H. Glycoprotein 96-activated dendritic cells induce a CD8-biased T cell response. Cell Stress Chaperones 2005;10:221-229.
30. Garnier C, Barbier P, Gilli R, Lopez C, Peyrot V, Briand C. Heat-shock protein 90 (hsp90) binds in vitro to tubulin dimmer and inhibits microtubule formation. Biochem Biophys Res Commun 1998;250:414-419.
31. Tskhovrebova L, Trinick J. Titin: Properties and family relationships. Mol Cell Biol 2003;4:679-689.
32. Tskhovrebova L, Trinick J. Properties of titin immunoglobulin and Fibronectin-3 domains. J Biol Chem 2004;279:46351-46354.
33. Zuckerman ST, Kao WJ. Effect of surface-adsorbed proteins and phosphorylation inhibitor AG18 on intracellular protein expression in adherent macrophages. Biomaterials 2006;27: 3745-3757.
34. Gross SR, Kinzy TG. Translation elongation factor 1A is essential for regulation of the actin cytoskeleton and cell morphology. Nat Struct Mol Biol 2005;12:772-778.
35. Tolnay M, Vereshchagina LA, Tsokos GC. Heterogeneous nuclear ribonucleoprotein D0B is a sequence-specific DNA-binding protein. Biochem J 1999;338:417-425.
36. Tolnay M, Tsokos GC. Complement receptor 2 in the regulation of the immune response. Clin Immunol Immunopathol 1998;88:123-132.
37. Tolnay M, Lambris JD, Tsokos GC. Transcriptional regulation of the complement receptor 2 gene: Role of a heterogeneous nuclear ribonucleoprotein. J Immunol 1997;159:5492-5501.
38. Tolnay M, Tsokos GC. Serum regulates the expression of complement receptor 2 on human B cell lines. Immunopharmacol Immunotoxicol 200C;22:205-219.
39. Gros L, Saparbaev MK, Laval J. Enzymology of the repair of free radicals-induced DNA damage. Oncogene 2002;21:8905-8925.
40. Johnstone RW, Trapani JA. Transcription and growth regulatory functions of the HIN-200 family of proteins. Mol Cell Biol 1999;19:5833-5838.
41. Ludlow LEA, Johnstone RW, Clarke CJP. The HIN-200 family: More than interferon-inducible genes? Exp Cell Res 2005;308:1-17.
42. Briggs RC, Shults KE, Flye LA, McClintock-Treep SA, Jagasia MH, Goodman SA, Boulos FI, Jacobberger JW, Stelzer GT, Head DR. Dysregulated human myeloid nuclear differentiation antigen expression myelodysplastic syndromes: Evidences for a role in apoptosis. Cancer Res 2006;66:4645-4651.
43. Landsberg MJ, Moran-Jones K, Smith R. Molecular recognition of an RNA trafficking element by heterogeneous nuclear ribonucleoprotein A2. Biochemistry 2006;45:3943-3951.
44. Fahling M, Mrowka R, Steege A, Martinka P, Persson PB, Thiele BJ. Heterogeneous nuclear ribonucleoprotein-A2/B1 modulate collagen prolyl 4-hydroxylase, α(I) mRNA stability. J Biol Chem 2006;281:9279-9286.
45. Alkan SA, Martincic K, Milcarek C The hnRNPs F and H2 bind to similar sequences to influence gene expression. Biochem J 2006;393:361-371.
46. Lankes WT, Heinz F. Moesin: A member of the protein 4.1-Talin-Ezrin family of proteins. Proc Natl Acad Sci USA 1991; 88:8297-8301.
47. Hirao M, Sato N, Kondo T, Yonemura S, Monden M, Sasaki T, Takai Y, Tsukita S, Tsukita S. Regulations mechanism of ERM (Ezrin/Radixin/Moesin) protein/plasma membrane association: Possible involvement of phosphatidylinositol turnover and Rho-dependent signaling pathway. J Cell Biol 1996;135:37-51.
48. Pearson MA, Reczek D, Bretscher A, Karplus PA. Structure of the ERM protein moesin reveals the FERM domain fold masked by an extended actin binding tail domain. Cell 2000;101:259-270.
49. Bretscher A, Edwards K, Fehon RG. ERM proteins and merlin: Integrators at the cell cortex. Mol Cell Biol 2002;3:586-599.
50. Freeley M, Volkov Y, Kelleher D, Long A. Stimulus-induced phosphorylation of PKC θ at the C-terminal hydrophobic motif in human T lymphocytes. Biochem Biophys Res Commun 2005;334:619-630.
51. Ivetic A, Ridley AJ. Ezrin/radixin/moesin proteins and Rho GTPase signaling in leukocytes. Immunology 2004;112:165-176.
52. Delon J, Kaibuchi K, Germain RN. Exclusion of CD43 from the immunological synapse is mediated by phosphorylation-regulated relocation of the cytoskeletal adaptor moesin. Immunity 2001;15:691-701.
53. Kondo T, Takeuchi K, Doi Y, Yonemura S, Nagata S, Tsukita S, Tsukita S. ERM (Ezrin/Radixin/Moesin)-based molecular mechanism of microvillar breakdown at an early stage of apoptosis. J Cell Biol 1997;139:749-758.
54. Defacque H, Egeberg M, Habermann A, Diakonova M, Roy C, Mangeat P, Voelter W, Marriott G, Pfannstiel J, Faulstich H, Griffiths G. Involvement of ezrin/moesin in de novo actin assembly on phagosomal membranes. EMBO J 2000;19:199-212.
55. Brown MJ, Nijhara R, Hallam JA, Gignac M, Yamada KM, Erlandsen SL, Delon J, Kruhlak M, Shaw S. Chemokine stimulation of human peripheral blood T lymphocytes induces rapid dephosphorylation of ERM proteins, which facilitates loss of microvilli and polarization. Blood 2003;102:3890-3899.
56. Krieg J, Hunter T. Identification of the two major epidermal growth factor-induced tyrosine phosphorylation sites in the microvillar core protein ezrin. J Biol Chem 1992;267:19258-19265.
57. Honore S, Pasquier E, Braguer D. Understanding microtubule dynamics for improved cancer therapy. Cell Mol Life Sci 2005;62:3039-3056.
58. Nogales E. Structural insights into microtubule function. Annu Rev Biophys Biomol Struct 2001;30:397-420.
59. Rasenick MM, Donati RJ, Popova JS, Yu JL. Tubulin as a regulator of G-protein signaling. Methods Enzymol 2004;390: 389-403.
60. Fernandez JA, Keshvara LM, Peters JD, Furlong MT, Harrison ML, Geahlen RL. Phosphorylation- and activation-independent association of the tyrosine kinase Syk and the tyrosine kinase substrates Cbl and Vav with tubulin in B-cells. J Biol Chem 1999;274:1401-1406.
61. Peters JD, Furlong MT, Asai DJ, Harrison ML, Geahlen RL. Syk, activated by cross-linking the B-cell antigen receptor, localizes to the cytosol where it interacts with and phosphorylates α-tubulin on tyrosine. J Biol Chem 1996;271:4755-4762.
62. Navara CS. The spleen tyrosine kinase (Syk) in human disease, implications for design of tyrosine kinase inhibitor based therapy. Curr Pharm Des 2004;10:1739-1744.
63. Peters HI, Change YE, Traugh JA. Phosphorylation of elongation factor 1 (EF-1) by protein kinase C stimulates DGP/GTP-exchange activity. Eur J Biochem 1995;234:550-556.
64. Liu G, Grant WM, Persky D, Latham VM, Singer RH, Condeelis J. Interactions of elongation factor la with F-actin and β-actin mRNA: Implications for anchoring mRNA in cell protrusions. Mol Biol Cell 2002;13:579-592.
65. Latham VM, Yu EHS, Tullio AN, Adelstein RS, Singer RH. A Rho-dependent signaling pathway operating through myosin localizes β-actin mRNA in fibroblasts. Curr Biol 2001;11:1010-1016.
66. Shestakova EA, Singer RH, Condeelis J. The physiological significance of β-actin mRNA localization in determining cell polarity and directional motility. Proc Natl Acad Sci USA 2001;98:7045-7050.
67. Lau J, Castelli LA, Lin ECK, Macaulay SL. Identification of elongation factor 1α as a potential associated binding partner for Akt2. Mol Cell Biochem 2006;286:17-22.
68. Venema RC, Peters HI, Traugh JA. Phosphorylation of Valyl-tRNA synthetase and elongation factor 1 in response to phorbol esters is associated with stimulation of both activities. J Biol Chem 1991;266:11993-11998.
69. Venema RC, Peters HI, Traugh JA. Phosphorylation of elongation factor 1 (EF-1) and Valyl-tRNA synthetase by Protein Kinase C and stimulation of EF-1 activity. J Biol Chem 1991;266:12574-12580.
70. Swartz JM, Bystrom J, Dyer KD, Nitto T, Wynn TA, Rosenberg HF. Plasminogen activator inhibitor-2 (PAI-2) in eosinophilic leukocytes. J Leuk Bio 2004;76:812-819.
71. Haile WB, Coleman JL, Benach JL. Reciprocal upregulation of urokinase plasminogen activator and its inhibitor, PAI-2, by Borrelia burgdorferi affects bacterial penetration and host-inflammatory response. Cell Microbiol 2006;8:1349-1360.
72. Varro A, Noble PJM, Pritchard DM, Kennedy S, Hart CA, Dimaline R, Dockray GJ. Helicobacter pylori induces plasminogen activator inhibitor 2 in gastric epithelial cells through Nuclear Factor κB and RhoA: Implications for invasion and apoptosis. Cancer Res 2004;64:1695-1702.
73. Chen G, Ward MF, Sama AE, Wang H. Extracellular HMGB1 as a proinflammatory cytokine. J Interferon Cytokine Res 2004;24:329-333.
74. Andersson U, Wang H, Palmbald K, Aveberger AC, Bloom O, Erlandsson-Harris H, Janson A, Kokkola R, Zhang M, Yang H, Tracey KJ. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med 2000;192:565-570.
75. Park JS, Svetkauskaite D, He Q, Kim JY, Strassheim D, Ishizaka A, Abraham E. Involvement of Toll-like Receptors 2 and 4 in cellular activation by High Mobility Group Box 1 protein. J Biol Chem 2004;279:7370-7377.
76. Park JS, Gamboni-Robertson F, He Q, Svetkauskaite D, Kim JY, Strassheim D, Sohn JW, Yamada S, Maruyama I, Banerjee A, Ishizaka A, Abraham E. High mobility group box 1 protein interacts with multiple Toll-like receptors. Am J Physiol Cell Physiol 2006;290:C917-C924.
77. Sarkar A, Duncan M, Hart J, Hertlein E, Guttridge DC, Wewers MD. ASC directs NF-κB activation by regulating receptor interacting protein-2 (RIP2) caspase-1 interactions. J Immunol 2006;176:4979-4986.